Clinical trial
The COvid19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
NCT05543642 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The COvid19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
- Lead sponsor
- Oregon Health and Science University
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 11, 2022
- Completion date
- August 14, 2026
- Enrollment
- 129 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.